Value through Innovation27 July 2016

Clinical Study Results

  • PROMYCIN ® - Head and Neck Neoplasms
    Clinical Study Number 1164.3
    Study Indication Head and Neck Neoplasms
    Product PROMYCIN ®
    Generic Name Porfiromycin
    Lab Code
    Clinical Phase I
    Study Title

    A Phase I Intensive Pharmacokinetic Study of Porfiromycin in Head and Neck Cancer and Other Cancer Patients with Solid Tumors who Receive Radiation Therapy

    Study Document Trial synopsis 1164.3_CO english
  • PROMYCIN ® - Head and Neck Neoplasms
    Clinical Study Number 1164.4
    Study Indication Head and Neck Neoplasms
    Product PROMYCIN ®
    Generic Name Porfiromycin
    Lab Code
    Clinical Phase III
    Study Title

    A Phase III, Double-Blind, Randomized, Placebo-Controlled Study of Porfrromycin used as an Adjuvant to Radiation Therapy in Postoperative Head and Neck Cancer Patients

    Study Document Trial synopsis 1164.4 english

Clinical Trial Registry and structured study results. Find here protocol information for all clinical study types.

European Trial Register of EU studies.